SK283055B6 - Farmaceutický prostriedok obsahujúci 4-oxobutánové kyseliny - Google Patents

Farmaceutický prostriedok obsahujúci 4-oxobutánové kyseliny Download PDF

Info

Publication number
SK283055B6
SK283055B6 SK180-99A SK18099A SK283055B6 SK 283055 B6 SK283055 B6 SK 283055B6 SK 18099 A SK18099 A SK 18099A SK 283055 B6 SK283055 B6 SK 283055B6
Authority
SK
Slovakia
Prior art keywords
oxobutanoic
benzyl
group
acid
aryl
Prior art date
Application number
SK180-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK18099A3 (en
Inventor
Grard Moinet
Liliane Doare
Micheline Kergoat
Philippe Maizeray
Didier Mesangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK18099A3 publication Critical patent/SK18099A3/sk
Publication of SK283055B6 publication Critical patent/SK283055B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK180-99A 1996-08-16 1997-08-05 Farmaceutický prostriedok obsahujúci 4-oxobutánové kyseliny SK283055B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9610254A FR2752422B1 (fr) 1996-08-16 1996-08-16 Composition pharmaceutique contenant des acides 4-oxo-butanoiques
PCT/EP1997/004252 WO1998007681A1 (fr) 1996-08-16 1997-08-05 Compositions pharmaceutiques contenant des acides 4-oxo-butanoiques

Publications (2)

Publication Number Publication Date
SK18099A3 SK18099A3 (en) 2000-03-13
SK283055B6 true SK283055B6 (sk) 2003-02-04

Family

ID=9495089

Family Applications (1)

Application Number Title Priority Date Filing Date
SK180-99A SK283055B6 (sk) 1996-08-16 1997-08-05 Farmaceutický prostriedok obsahujúci 4-oxobutánové kyseliny

Country Status (30)

Country Link
US (1) US6143787A (id)
EP (1) EP0925273B1 (id)
JP (1) JP3105545B2 (id)
KR (1) KR100488430B1 (id)
CN (1) CN1082370C (id)
AR (1) AR009251A1 (id)
AT (1) ATE208364T1 (id)
AU (1) AU725440B2 (id)
BR (1) BR9711315A (id)
CA (1) CA2263348C (id)
CY (1) CY2298B1 (id)
CZ (1) CZ294165B6 (id)
DE (1) DE69708130T2 (id)
DK (1) DK0925273T3 (id)
ES (1) ES2166098T3 (id)
FR (1) FR2752422B1 (id)
HK (1) HK1021728A1 (id)
HU (1) HUP0004223A3 (id)
ID (1) ID17875A (id)
NO (1) NO312290B1 (id)
PL (1) PL187371B1 (id)
PT (1) PT925273E (id)
RU (1) RU2175966C2 (id)
SI (1) SI0925273T1 (id)
SK (1) SK283055B6 (id)
TR (1) TR199900329T2 (id)
TW (1) TW438764B (id)
UA (1) UA57031C2 (id)
WO (1) WO1998007681A1 (id)
ZA (1) ZA977327B (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04318852A (ja) * 1991-04-18 1992-11-10 Fujitsu Ltd レジスト・パターン形成方法
WO2002100341A2 (en) 2001-06-12 2002-12-19 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
FR2832633B1 (fr) * 2001-11-28 2004-09-24 Lipha Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete
FR2832925B1 (fr) * 2001-12-03 2006-07-14 Lipha Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation
FR2834214B1 (fr) * 2001-12-28 2004-09-24 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete
FR2834640B1 (fr) * 2002-01-11 2004-09-24 Lipha Composition pharmaceutique comprenant une glitazone et un acide 4-oxobutanoique et son utilisation pour traiter le diabete
EP1556085A4 (en) * 2002-11-01 2012-08-22 Wellstat Therapeutics Corp COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
AU2003275939A1 (en) * 2002-11-08 2004-06-07 Novo Nordisk A/S Safe chemical uncouplers for the treatment of obesity
FR2849598B1 (fr) * 2003-01-07 2006-09-22 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete, par augmentation du nombre de cellules des ilots de langerhans
FR2849599B1 (fr) * 2003-01-07 2006-12-29 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete
CN101912380A (zh) * 2003-04-15 2010-12-15 维尔斯达医疗公司 用于治疗代谢紊乱的化合物
ES2368692T3 (es) 2007-12-03 2011-11-21 Merck Patent Gmbh Utilización de derivados del ácido 4-oxobutanoico en el tratamiento de patologías asociadas con trastornos inmunológicos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK523288A (da) * 1987-10-06 1989-04-07 Hoffmann La Roche Aminosyrederivater
US5250517A (en) * 1987-10-06 1993-10-05 Hoffmann-La Roche Inc. Renin inhibiting compounds
US5055466A (en) * 1987-11-23 1991-10-08 E. R. Squibb & Sons, Inc. N-morpholino derivatives and their use as anti-hypertensive agents
CA1329680C (en) * 1987-11-23 1994-05-17 Harold Norris Weller, Iii N-heterocyclic alcohol derivatives

Also Published As

Publication number Publication date
NO312290B1 (no) 2002-04-22
BR9711315A (pt) 1999-08-17
HK1021728A1 (en) 2000-06-30
CA2263348A1 (fr) 1998-02-26
SI0925273T1 (en) 2002-04-30
UA57031C2 (uk) 2003-06-16
TR199900329T2 (xx) 1999-04-21
CN1227538A (zh) 1999-09-01
FR2752422A1 (fr) 1998-02-20
WO1998007681A1 (fr) 1998-02-26
PL331645A1 (en) 1999-08-02
PL187371B1 (pl) 2004-06-30
CN1082370C (zh) 2002-04-10
EP0925273A1 (fr) 1999-06-30
CA2263348C (en) 2008-05-13
CY2298B1 (en) 2003-07-04
HUP0004223A2 (hu) 2001-04-28
CZ294165B6 (cs) 2004-10-13
KR100488430B1 (ko) 2005-05-10
SK18099A3 (en) 2000-03-13
NO990707L (no) 1999-02-15
KR20000068106A (ko) 2000-11-25
DK0925273T3 (da) 2002-02-18
US6143787A (en) 2000-11-07
RU2175966C2 (ru) 2001-11-20
JP2000506543A (ja) 2000-05-30
ZA977327B (en) 1998-03-30
JP3105545B2 (ja) 2000-11-06
AR009251A1 (es) 2000-04-12
PT925273E (pt) 2002-04-29
HUP0004223A3 (en) 2001-12-28
DE69708130D1 (de) 2001-12-13
DE69708130T2 (de) 2002-06-20
AU3942297A (en) 1998-03-06
TW438764B (en) 2001-06-07
AU725440B2 (en) 2000-10-12
ES2166098T3 (es) 2002-04-01
ID17875A (id) 1998-02-05
CZ49899A3 (cs) 1999-05-12
EP0925273B1 (fr) 2001-11-07
FR2752422B1 (fr) 1998-11-06
NO990707D0 (no) 1999-02-15
ATE208364T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
FI89355C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 1-aminobut-3-en-foereningar
US4943587A (en) Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition
EP0804437B1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
SK283055B6 (sk) Farmaceutický prostriedok obsahujúci 4-oxobutánové kyseliny
DD201790A5 (de) Verfahren zur herstellung von 3-aryl-5-isothiazolen
CA1137497A (en) Mercaptoacyldihydropyrazole carboxylic acid derivatives
US4483861A (en) Antihypertensive sulfur-containing compounds
CZ280564B6 (cs) Z-2-Acylamino-3-monosubstituované propenoáty, způsoby jejich výroby a antibakteriální přípravky s jejich obsahem
US3563997A (en) Certain thieno(2,3-c)pyridines
US4521619A (en) Therapeutically useful sulphur-containing benzylidene derivatives
JPH0583551B2 (id)
ITRM20000341A1 (it) Composti utili per la preparazione di medicamenti ad attivita' inibitrice della fosfodiesterasi iv.
AU2016381152A1 (en) Indolizine derivatives, composition and methods of use
IE883598L (en) Acyl derivatives of hydroxy pyrimidines
WO1999016763A1 (fr) Derive de cetone et son utilisation en medecine
US3956501A (en) N-substituted glycinates
MXPA99001482A (en) Pharmaceutical composition containing 4-oxo-butynic acids
SU1535382A3 (ru) Способ получени 2-метил-3-N-(2-пиридил)-карбамоил-4-замещенный алкокси-2Н-1,2-бензотиазин-1,1-диоксидов
FR2539414A1 (fr) Derives de la pyrimidine, leur procede de preparation et les medicaments ayant une activite sur le systeme nerveux central qui en contiennent
NZ207840A (en) Diphenylazomethine derivatives and pharmaceutical compositions
US3462449A (en) Substituted 4,5,6,7-tetrahydro-delta**2,a-benzothiazolineacetic acid esters
KR840001285B1 (ko) 2-이미다졸린 유도체류의 제조방법
RU2096407C1 (ru) Производные катехола и способ их получения
JPH11279157A (ja) バルビツール酸誘導体およびそれらからなる骨・軟骨疾患予防・治療薬
JPH0584317B2 (id)

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100805